Saturday, August 23, 2025

Organigram: Analysts Upgrade Targets Following BAT Investment

On March 9th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they received a C$221 million strategic investment from British American Tobacco, which is the equalivent to 53.3 million shares or a 19.9% stake in the cannabis company.

Organigram currently has 14 analysts covering the company with a weighted 12-month price target of C$3.58. This is down from last month, which was C$2.45. Two analysts have strong buys while another two have buy ratings, and the majority, nine analysts, have hold ratings, and one has a sell rating on the name

Five analysts have changed their 12-month price targets after the news:

  • ATB Capital markets raises target price to C$4.20 from C$1.90
  • Eight Capital raises target price to C$3.85 from C$2.40
  • CIBC raises target price to C$5.00 from C$4.25
  • Cantor Fitzgerald raises target price to C$6.00 from C$3.50
  • Raymond James raises target price to C$6.00 from C$3.00
  • Haywood Capital raises target price to C$4.75 from C$2.00

Below are excerpts from a few analyst’s notes.

Raymond James says that this investment makes Organigram one of the “best-capitalized cannabis companies.” Raymond James now expects Organigram to hold a 12.5% market share of the Canadian market share. This is up from 6.5% by 2025. Below you can see their new revenue estimates.

Cantor Fitzgerald says that with only C$30 million of the whole C$221 million investment going towards joint product development, OGI will have roughly C$266 million of free money on their balance sheet. They expect Organigram to start looking at M&A with all that money.

Haywood says that this investment “provides a significant boost on the optionality for OGI going forward. We believe this is a positive transaction for OGI and see an increased probability for the company to enter other geographic markets.” The firm also changed its estimate methodology, now basing it on 10x EV/Revenue, compared to the prior estimate being based on a multiple for EV/EBITDA.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

Why Grade Beats Size in Silver Mining | Frank Basa – Nord Precious Metals

Are Investors Missing the Start of the Next Commodity Supercycle? | Morgan Lekstrom – NexMetals

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

Sigma Lithium Sees BMO Lift Target To $25 Following Updated Feasibility Study

BMO Capital Markets this week raised their price target on Sigma Lithium Resources (TSXV: SGML)....

Sunday, April 17, 2022, 11:05:00 AM

Canaccord Reiterates Rating On CloudMD After Quarterly Results

On August 25, CloudMD Software & Services (TSXV: DOC) reported their second quarter financial results....

Saturday, August 28, 2021, 03:10:00 PM

Meta Platforms: Canaccord Anticipates Headwinds To Persist, Cuts Target To $200

On October 26th, Meta Platforms Inc (Nasdaq: META) reported its third-quarter financial results. The company...

Thursday, November 3, 2022, 12:52:00 PM

BMO Resumes Coverage On Tricon Residential After US IPO

Earlier this month, Tricon Residential (TSX: TCN) announced that they closed their U.S. IPO selling...

Sunday, October 31, 2021, 12:03:00 PM

Enthusiast Gaming Sees Canaccord Give Slight Lift To Price Target

On May 16th, Enthusiast Gaming (TSX: EGLX) reported its first quarter financial results. The company...

Sunday, May 22, 2022, 05:19:00 PM